1 - 25 of 51 results for author:"Takemoto Y." in Literature citations
Results Customize
› Repeat search in UniProtKB (31)
| Impaired development of melanoblasts in the black-eyed white Mitf(mi-bw) mouse, a model for auditory-pigmentary disorders. Hozumi H., Takeda K., Yoshida-Amano Y., Takemoto Y., Kusumi R., Fukuzaki-Dohi U., Higashitani A., Yamamoto H., Shibahara S. Genes Cells 17:494-508(2012) · Mapped (8) |
| Diabetic impairment of C-kit bone marrow stem cells involves the disorders of inflammatory factors, cell adhesion and extracellular matrix molecules. Li T.S., Ikeda S., Kubo M., Ohshima M., Kurazumi H., Takemoto Y., Ueda K., Hamano K. PLoS ONE 6:e25543-e25543(2011) · Mapped (6) |
| Involvement of 14-3-3 proteins in the second epidermal growth factor-induced wave of Rac1 activation in the process of cell migration. Kobayashi H., Ogura Y., Sawada M., Nakayama R., Takano K., Minato Y., Takemoto Y., Tashiro E., Watanabe H., Imoto M. J. Biol. Chem. 286:39259-39268(2011) · Mapped (3) |
| DNA damage signaling is activated during cancer progression in human colorectal carcinoma. Oka K., Tanaka T., Enoki T., Yoshimura K., Ohshima M., Kubo M., Murakami T., Gondou T., Minami Y., Takemoto Y. et al. Cancer Biol. Ther. 9:246-252(2010) · Mapped (4) |
| Reduction of circulating soluble fms-like tyrosine kinase-1 plays a significant role in renal dysfunction-associated aggravation of atherosclerosis. Onoue K., Uemura S., Takeda Y., Somekawa S., Iwama H., Imagawa K., Nishida T., Morikawa Y., Takemoto Y., Asai O. et al. Circulation 120:2470-2477(2009) · Mapped (10) |
| Treatment with recombinant placental growth factor (PlGF) enhances both angiogenesis and arteriogenesis and improves survival after myocardial infarction. Takeda Y., Uemura S., Iwama H., Imagawa K., Nishida T., Onoue K., Takemoto Y., Soeda T., Okayama S., Somekawa S. et al. Circ. J. 73:1674-1682(2009) · Mapped (3) |
| Association of TLR4 polymorphisms with Behcet's disease in a Korean population. Horie Y., Meguro A., Ota M., Kitaichi N., Katsuyama Y., Takemoto Y., Namba K., Yoshida K., Song Y.W., Park K.S. et al. Rheumatology (Oxford) 48:638-642(2009) · Mapped (989) |
| Regulation of aldosterone and cortisol production by the transcriptional repressor neuron restrictive silencer factor. Somekawa S., Imagawa K., Naya N., Takemoto Y., Onoue K., Okayama S., Takeda Y., Kawata H., Horii M., Nakajima T. et al. Endocrinology 150:3110-3117(2009) · Mapped (3) |
| Study of cysteinyl leukotriene-1 receptor in rat renal ischemia-reperfusion injury. Matsuyama M., Funao K., Kawahito Y., Sano H., Chargui J., Touraine J.L., Takemoto Y., Nakatani T., Yoshimura R. Transplant. Proc. 40:2149-2151(2008) · Mapped (1) |
| Re-evaluation of heterogeneity in HLA-B*510101 associated with Behcet's disease. Takemoto Y., Naruse T., Namba K., Kitaichi N., Ota M., Shindo Y., Mizuki N., Gul A., Madanat W., Chams H. et al. Tissue Antigens 72:347-353(2008) · Mapped (992) |
| Increased levels of serum matrix metalloproteinase-3 in haemodialysis patients with dialysis-related amyloidosis. Naganuma T., Sugimura K., Uchida J., Tashiro K., Yoshimura R., Takemoto Y., Nakatani T. Nephrology (Carlton) 13:104-108(2008) · Mapped (2) |
| Polymorphism of IFN-gamma gene and Vogt-Koyanagi-Harada disease. Horie Y., Kitaichi N., Takemoto Y., Namba K., Yoshida K., Hirose S., Hasumi Y., Ota M., Inoko H., Mizuki N. et al. Mol. Vis. 13:2334-2338(2007) · Mapped (12) |
| Overexpression of cysteinyl LT1 receptor in prostate cancer and CysLT1R antagonist inhibits prostate cancer cell growth through apoptosis. Matsuyama M., Hayama T., Funao K., Kawahito Y., Sano H., Takemoto Y., Nakatani T., Yoshimura R. Oncol. Rep. 18:99-104(2007) · Mapped (3) |
| Polymorphisms of norepinephrine transporter and adrenergic receptor alpha1D are associated with the response to beta-blockers in dilated cardiomyopathy. Nonen S., Okamoto H., Fujio Y., Takemoto Y., Yoshiyama M., Hamaguchi T., Matsui Y., Yoshikawa J., Kitabatake A., Azuma J. Pharmacogenomics J. 8:78-84(2008) · Mapped (9) |
| A study of innate immunity in patients with end-stage renal disease: special reference to toll-like receptor-2 and -4 expression in peripheral blood monocytes of hemodialysis patients. Kuroki Y., Tsuchida K., Go I., Aoyama M., Naganuma T., Takemoto Y., Nakatani T. Int. J. Mol. Med. 19:783-790(2007) · Mapped (2) |
| Tyrosinase gene family and Vogt-Koyanagi-Harada disease in Japanese patients. Horie Y., Takemoto Y., Miyazaki A., Namba K., Kase S., Yoshida K., Ota M., Hasumi Y., Inoko H., Mizuki N. et al. Mol. Vis. 12:1601-1605(2006) · Mapped (15) |
| Immunohistochemical evidence for the localization of neurons containing the putative transmitter L-proline in rat brain. Takemoto Y., Semba R. Brain Res. 1073-1074:311-315(2006) · Mapped (2) |
| No positive association between adrenergic receptor variants of alpha2cDel322-325, beta1Ser49, beta1Arg389 and the risk for heart failure in the Japanese population. Nonen S., Okamoto H., Akino M., Matsui Y., Fujio Y., Yoshiyama M., Takemoto Y., Yoshikawa J., Azuma J., Kitabatake A. Br J Clin Pharmacol 60:414-417(2005) · Mapped (6) |
| Expression of peroxisome proliferator-activated receptor-gamma in renal ischemia-reperfusion injury. Matsuyama M., Yoshimura R., Hase T., Uchida J., Tsuchida K., Takemoto Y., Kawahito Y., Sano H., Nakatani T. Transplant. Proc. 37:1684-1685(2005) · Mapped (9) |
| Study of peroxisome proliferator-activated receptor (PPAR)-gamma in renal ischemia-reperfusion injury. Yoshimura R., Matsuyama M., Segawa Y., Tsuchida K., Takemoto Y., Kuratsukuri K., Kawahito Y., Shinka T., Sano H., Nakatani T. Transplant. Proc. 36:1946-1948(2004) · Mapped (1) |
| Identification of a new complementation group of the peroxisome biogenesis disorders and PEX14 as the mutated gene. Shimozawa N., Tsukamoto T., Nagase T., Takemoto Y., Koyama N., Suzuki Y., Komori M., Osumi T., Jeannette G., Wanders R.J. et al. |
| Peroxisomal localization in the developing mouse cerebellum: implications for neuronal abnormalities related to deficiencies in peroxisomes. Nagase T., Shimozawa N., Takemoto Y., Suzuki Y., Komori M., Kondo N. Biochim. Biophys. Acta 1671:26-33(2004) · Mapped (31) |
| Expression of lipoxygenase in human prostate cancer and growth reduction by its inhibitors. Matsuyama M., Yoshimura R., Mitsuhashi M., Hase T., Tsuchida K., Takemoto Y., Kawahito Y., Sano H., Nakatani T. Int. J. Oncol. 24:821-827(2004) · Mapped (9) |
| Relationship between lipoxygenase and human testicular cancer. Yoshimura R., Matsuyama M., Mitsuhashi M., Takemoto Y., Tsuchida K., Kawahito Y., Sano H., Nakatani T. Int. J. Mol. Med. 13:389-393(2004) · Mapped (10) |
| Genetic heterogeneity in Japanese patients with peroxisome biogenesis disorders and evidence for a founder haplotype for the most common mutation in PEX10 gene. Shimozawa N., Nagase T., Takemoto Y., Suzuki Y., Kondo N. Adv. Exp. Med. Biol. 544:71-71(2003) · Mapped (2) |